# Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.

> PubMed lists PMID 25358450 in Clinical pharmacokinetics as Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03 (month precision). PeptideScanner associated the retained record with the identity slug tesamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-25358450-tesamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-10-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25358450-tesamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-25358450-tesamorelin-v1.json
- Content SHA-256: `434e81724e79ccba0c4272f4d67972126d0c6e6557e9566944733b25ff64a665`

## Claims and source pins

### Headline

Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects. ([`pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404`](#source-pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404))

### Summary

PubMed lists PMID 25358450 in Clinical pharmacokinetics as Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03 (month precision). PeptideScanner associated the retained record with the identity slug tesamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404`](#source-pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404))

### Paragraph 1

PubMed lists PMID 25358450 in Clinical pharmacokinetics as Clinical Trial, Phase I, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-03 (month precision). PeptideScanner associated the retained record with the identity slug tesamorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404`](#source-pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404`](#source-pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404))

## Sources

<a id="source-pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404"></a>
- **Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects. · retained source version 1:2021-10-21:current:04a54e9cf404d6285e0ec8cffd340fa2780303f0bf8ba4a775cd16581b75403b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25358450/) (`pubmed-observation-pmid-25358450-2021-10-21-04a54e9cf404`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-25358450-tesamorelin-v1.json SHA-256: 434e81724e79ccba0c4272f4d67972126d0c6e6557e9566944733b25ff64a665.